Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Biomaterials
|
December 24, 2015
SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery
Carles Monterrubio, Guillem Pascual-Pasto, Francisco Cano, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 5, 2018
Glucosylated nanomicelles target glucose-avid pediatric patient-derived sarcomas
Alexandra Bukchin, Guillem Pascual-Pasto, Maria Cuadrado-Vilanova, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 2018
Ycf48 involved in the biogenesis of the oxygen-evolving photosystem II complex is a seven-bladed beta-propeller protein
Jianfeng Yu, Jana Knoppová, Franck Michoux, et al.
Oncotarget
|
August 25, 2018
The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma
Daniel Jose García-Domínguez, Lourdes Hontecillas-Prieto, Pablo Rodríguez-Núñez, et al.
Journal for Immunotherapy of Cancer
|
December 2, 2022
GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies
Guillem Pascual-Pasto, Brendan McIntyre, Rawan Shraim, et al.
Advanced Healthcare Materials
|
June 13, 2018
Tissue Compatibility of SN-38-Loaded Anticancer Nanofiber Matrices
Alejandro Manzanares, Camilo A Restrepo-Perdomo, Gaia Botteri, et al.
BMC Cancer
|
June 17, 2022
MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment
Laura Garcia-Gerique, Marta García, Alícia Garrido-Garcia, et al.
Cancer Letters
|
June 21, 2016
Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination
Guillem Pascual-Pasto, Nagore G Olaciregui, Monica Vila-Ubach, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 24, 2017
Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier
Guillem Pascual-Pasto, Nagore G Olaciregui, Javier A W Opezzo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 17, 2017
Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8
Carles Monterrubio, Sonia Paco, Nagore G Olaciregui, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Biomaterials
|
December 24, 2015
SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery
Carles Monterrubio, Guillem Pascual-Pasto, Francisco Cano, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 5, 2018
Glucosylated nanomicelles target glucose-avid pediatric patient-derived sarcomas
Alexandra Bukchin, Guillem Pascual-Pasto, Maria Cuadrado-Vilanova, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 2018
Ycf48 involved in the biogenesis of the oxygen-evolving photosystem II complex is a seven-bladed beta-propeller protein
Jianfeng Yu, Jana Knoppová, Franck Michoux, et al.
Oncotarget
|
August 25, 2018
The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma
Daniel Jose García-Domínguez, Lourdes Hontecillas-Prieto, Pablo Rodríguez-Núñez, et al.
Journal for Immunotherapy of Cancer
|
December 2, 2022
GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies
Guillem Pascual-Pasto, Brendan McIntyre, Rawan Shraim, et al.
Advanced Healthcare Materials
|
June 13, 2018
Tissue Compatibility of SN-38-Loaded Anticancer Nanofiber Matrices
Alejandro Manzanares, Camilo A Restrepo-Perdomo, Gaia Botteri, et al.
BMC Cancer
|
June 17, 2022
MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment
Laura Garcia-Gerique, Marta García, Alícia Garrido-Garcia, et al.
Cancer Letters
|
June 21, 2016
Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination
Guillem Pascual-Pasto, Nagore G Olaciregui, Monica Vila-Ubach, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 24, 2017
Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier
Guillem Pascual-Pasto, Nagore G Olaciregui, Javier A W Opezzo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 17, 2017
Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8
Carles Monterrubio, Sonia Paco, Nagore G Olaciregui, et al.
Page
of 5